$4.67 Billion is the total value of HHLR ADVISORS, LTD.'s 64 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BGNE | BEIGENE LTDsponsored adr | $885,685,000 | -14.2% | 5,472,259 | 0.0% | 18.98% | -11.9% | |
| MDLZ | MONDELEZ INTL INCcl a | $115,622,000 | -1.1% | 1,862,164 | 0.0% | 2.48% | +1.5% | |
| CYTEK BIOSCIENCES INC | $93,963,000 | -0.5% | 8,757,030 | 0.0% | 2.01% | +2.2% | ||
| IMAB | I MABsponsored ads | $81,166,000 | -30.4% | 7,182,850 | 0.0% | 1.74% | -28.5% | |
| YSG | YATSEN HLDG LTDads | $62,700,000 | +125.8% | 40,451,713 | 0.0% | 1.34% | +131.7% | |
| GOSS | GOSSAMER BIO INC | $62,114,000 | -3.6% | 7,420,974 | 0.0% | 1.33% | -1.0% | |
| ENFUSION INCcl a | $50,797,000 | -19.7% | 4,975,183 | 0.0% | 1.09% | -17.6% | ||
| BBIO | BRIDGEBIO PHARMA INC | $48,687,000 | -10.5% | 5,362,014 | 0.0% | 1.04% | -8.1% | |
| PLTK | PLAYTIKA HLDG CORP | $43,436,000 | -31.5% | 3,280,699 | 0.0% | 0.93% | -29.7% | |
| KNSA | KINIKSA PHARMACEUTICALS LTD | $28,295,000 | -2.5% | 2,920,023 | 0.0% | 0.61% | +0.2% | |
| UBER | UBER TECHNOLOGIES INC | $22,792,000 | -42.7% | 1,114,000 | 0.0% | 0.49% | -41.1% | |
| SOHU | SOHU COM LTDsponsored ads | $13,290,000 | -1.5% | 802,034 | 0.0% | 0.28% | +1.1% | |
| HTHT | HUAZHU GROUP LTDsponsored ads | $11,552,000 | +15.5% | 303,200 | 0.0% | 0.25% | +18.7% | |
| ACMR | ACM RESH INC | $11,289,000 | -18.7% | 670,755 | 0.0% | 0.24% | -16.6% | |
| MLCO | MELCO RESORTS AND ENTMNT LTDadr | $9,769,000 | -24.7% | 1,698,877 | 0.0% | 0.21% | -22.9% | |
| ALLO | ALLOGENE THERAPEUTICS INC | $9,120,000 | +25.1% | 800,000 | 0.0% | 0.20% | +28.3% | |
| SNOW | SNOWFLAKE INCcl a | $8,761,000 | -39.3% | 63,000 | 0.0% | 0.19% | -37.5% | |
| FMTX | FORMA THERAPEUTICS HLDGS INC | $7,579,000 | -25.9% | 1,100,000 | 0.0% | 0.16% | -24.3% | |
| DYN | DYNE THERAPEUTICS INC | $6,870,000 | -28.7% | 1,000,000 | 0.0% | 0.15% | -26.9% | |
| IPSC | CENTURY THERAPEUTICS INC | $5,158,000 | -33.3% | 614,095 | 0.0% | 0.11% | -31.1% | |
| EM | SMART SH GLOBAL LTDads | $4,529,000 | -13.9% | 4,080,000 | 0.0% | 0.10% | -11.8% | |
| TUYA | TUYA INCsponsered ads | $4,426,000 | -11.5% | 1,689,359 | 0.0% | 0.10% | -8.7% | |
| ADCT | ADC THERAPEUTICS SA | $3,975,000 | -45.9% | 500,000 | 0.0% | 0.08% | -44.4% | |
| SURROZEN INC | $3,528,000 | -2.3% | 1,200,000 | 0.0% | 0.08% | +1.3% | ||
| ROOT | ROOT INC | $3,094,000 | -39.6% | 2,600,000 | 0.0% | 0.07% | -38.3% | |
| PRLD | PRELUDE THERAPEUTICS INC | $3,045,000 | -24.3% | 583,333 | 0.0% | 0.06% | -22.6% | |
| BEDU | BRIGHT SCHOLAR ED HLDGS LTDsponsored ads | $2,910,000 | +21.7% | 3,985,797 | 0.0% | 0.06% | +24.0% | |
| ALGS | ALIGOS THERAPEUTICS INC | $2,862,000 | -43.7% | 2,365,064 | 0.0% | 0.06% | -42.5% | |
| PATH | UIPATH INCcl a | $2,729,000 | -15.7% | 150,000 | 0.0% | 0.06% | -14.7% | |
| MOGU INCspon ads | $1,959,000 | -36.1% | 870,580 | 0.0% | 0.04% | -34.4% | ||
| MNSO | MINISO GROUP HLDG LTDsponsored ads | $1,981,000 | +0.7% | 252,322 | 0.0% | 0.04% | +2.4% | |
| CCC INTELLIGENT SOLUTIONS HL | $1,840,000 | -16.7% | 200,000 | 0.0% | 0.04% | -15.2% | ||
| PYXIS ONCOLOGY INC | $1,819,000 | -41.1% | 764,406 | 0.0% | 0.04% | -39.1% | ||
| LEAPU | RIBBIT LEAP LTDunit 99/99/9999 | $498,000 | 0.0% | 50,000 | 0.0% | 0.01% | +10.0% | |
| SURROZEN INC*w exp 08/01/203 | $77,000 | -23.0% | 399,999 | 0.0% | 0.00% | 0.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BEIGENE LTD | 20 | Q3 2023 | 26.0% |
| JD.COM INC | 20 | Q3 2023 | 13.1% |
| IQIYI INC | 20 | Q3 2023 | 12.3% |
| MONDELEZ INTL INC | 20 | Q3 2023 | 5.9% |
| KINIKSA PHARMACEUTICALS LTD | 20 | Q3 2023 | 1.6% |
| SOHU COM LTD | 20 | Q3 2023 | 0.6% |
| PINDUODUO INC | 19 | Q3 2023 | 16.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 2.3% |
| BRIDGEBIO PHARMA INC | 18 | Q3 2023 | 3.4% |
| MELCO RESORTS AND ENTMT LTD | 18 | Q1 2023 | 2.8% |
View HHLR ADVISORS, LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| I-Mab | June 30, 2023 | 15,891,211 | 8.3% |
| BeiGene, Ltd. | February 14, 2023 | 147,043,058 | 10.9% |
| Gossamer Bio, Inc. | February 14, 2023 | 4,974,041 | 5.3% |
| On Holding AG | February 14, 2023 | 5,468,504 | 1.9% |
| Root, Inc. | February 14, 2023 | 138,977 | 1.5% |
| Yatsen Holding Ltd | February 14, 2023 | 300,560,602 | 19.1% |
| iQIYI, Inc. | July 11, 2022 | 149,075,912 | 5.0% |
| Apellis Pharmaceuticals, Inc. | February 14, 2022 | ? | ? |
| Beam Therapeutics Inc. | February 14, 2022 | ? | ? |
| Futu Holdings Ltd | February 14, 2022 | 2 | - |
View HHLR ADVISORS, LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 4 | 2024-02-01 |
| 13F-HR | 2023-11-14 |
View HHLR ADVISORS, LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.